Financing, Equity Capital Markets

Syros Pharmaceuticals, Inc.

04/19
|
$65.0 Million
Piper Sandler served as bookrunner for Syros Pharmaceuticals, Inc. on a confidentially marketed follow-on offering
Sub-Type
CMFO
Sub-Sector
Biopharma